Oncology Vol 29 No 10

Chemotherapy-Induced Cardiomyopathy: Clinical Scenarios and Challenges

October 15, 2015

We will discuss the deleterious cardiovascular effects of anthracyclines and HER2-targeted agents in a case-based format, as well as specific approaches to prevention and treatment of associated cardiotoxicity.

Bevacizumab and Glioblastoma: The Ecstasy and the Agony

October 15, 2015

The absence of any effective combinatorial therapy in patients progressing on bevacizumab and evidence supporting both continuation and discontinuation of bevacizumab in this setting remain important areas for additional clinical trial evaluation in order to better guide our therapeutic decision making in the clinic.

Salivary Gland Cancers: The Challenges of Progress in Rare Tumors

October 15, 2015

The diversity and complexity, combined with the rarity of salivary gland malignancies, lead to definite and distinct challenges in their study, and consequently in advancing treatment options for affected patients.